2014 Leads Specialization 
Pharmaceutical Technology
JANUARY 23, 2023
Out of the seven biologics approved to treat moderate to severe CD in adults, only the anti-TNFαs, Remicade (infliximab), and Humira (adalimumab), have been approved for paediatric patients, with Humira receiving the most recent approval in 2014.
Clarivate
SEPTEMBER 11, 2024
Approximately 43% of people with MCI develop dementia due to Alzheimer’s disease within 5 years (Roberts, 2014) (Figure 1). Underdiagnosis, misdiagnosis, and slow diagnosis are common (Lang, 2017; Alzheimer’s Disease International, 2021; Chairi, 2022; Gjøra, 2024), and often lead to delayed care. 2024; Quanterix, 2024). Roberts, R.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
NOVEMBER 16, 2023
Using generative AI to create AI representatives for team leads wasn’t the most obvious application of the technology, but it is proving to provide them tremendous support and value in project planning.” Moment to Life Coordinating multidisciplinary efforts can be a challenge for any agency.
PM360
SEPTEMBER 8, 2023
GoodRx is a leading resource for people with diabetes to find prescription savings and information, having helped almost 2.5 While there are recent efforts to curb the prices of insulin, GoodRx research 5 shows the average cash price for insulin rose 54% from 2014 to 2019, and only decreased 7.1% First, some good news about diabetes.
European Pharmaceutical Review
DECEMBER 21, 2022
Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure. During his time at Genentech Stefan has advanced several small molecules and new modalities (antibody‑drug conjugates, oligonucleotides and peptides) into the clinic as lead chemist and technical development leader.
CloserIQ
OCTOBER 10, 2018
Founded 2014. They’ve worked with leading clients such as Twitter and Mercedes Benz. Founded 2014. BondLink is a fintech company specializing in the municipal bond market. CloudHealth Technologies offers a market-leading cloud management platform that helps businesses optimize different cloud environments.
pharmaphorum
OCTOBER 26, 2022
Founded in 1935 by Chiesi’s grandfather of the same name, Chiesi Group focuses on respiratory conditions, special care, and on rare diseases, including lysosomal storage disorders and rare haematological and ophthalmological diseases. “An About the author. He serves as a Board Member on the Board of the Chiesi Group.
Expert insights. Personalized for you.
59 
Let's personalize your content